Harold J. Burstein, MD, PhD, is Professor of Medicine at Harvard Medical School. He currently practices as a Medical Oncologist at Dana-Farber Cancer Institute in Boston, Massachusetts.
Dr. Burstein received his medical degree from Harvard Medical School, where he also earned a PhD in immunology. He completed his training in Internal Medicine at Massachusetts General Hospital and in Medical Oncology at Dana-Farber Cancer Institute, both located in Boston.
His clinical research interests include novel treatments for early- and advanced-stage breast cancer, including neoadjuvant treatments, concurrent radiotherapy/chemotherapy, and biological therapies. He is also interested in quality of life and health behavior among women with breast cancer. Dr. Burstein has written extensively on breast cancer, and his work has been published in leading medical journals such as the New England Journal of Medicine and the Journal of Clinical Oncology.
Dr. Burstein serves on multiple international breast cancer committees, including the National Comprehensive Cancer Network Breast Cancer Panel, the St. Gallen Breast Cancer Panel, and the Alliance Breast Cancer Committee. He is the Chair of the American Society of Clinical Oncology guidelines on endocrine therapy for breast cancer. He also serves as an Associate Editor for Cancer Education at the Journal of Clinical Oncology.